I have spent thirty years operating as a “hybrid” leader—exactly fifteen years as a serial entrepreneur and fifteen years in the Fortune 500 C-suite. I’ve seen the view from the top at Keurig as Chief Innovation Officer, and I’ve felt the adrenaline of leading Green Mountain Energy to a $100 million exit. I have seen billion-dollar launches soar, and I have seen “sure things” crumble.
The candid truth is that most product launches fail because leadership falls in love with the spreadsheet and ignores the biology. When a launch flops, it usually isn’t because of a supply chain hiccup. It’s because the organization is “Scaling the Beta”—rushing a product into the wild that is still triggering cortisol (stress) in the customer instead of a cascade of pleasure chemicals. For a Board Chair or a Fortune 500 CEO, this mistake is more than just an R&D write-off; it is a massive, avoidable hit to your credibility.
By the time you finish this article, you will understand how to use the Rx of Preference to diagnose why your previous launches may have stuttered and how to ensure your next one is an undeniable success. We are going to stop guessing and start treating your GTM strategy as a “Business Art” project.
The Fatal Sin of Scaling the Beta
In the race to satisfy the quarterly expectations of Private Equity Partners or a Nominating Committee, many organizations hit the “go” button far too early. I call this Scaling the Beta.
This happens when you take a product that is “good enough” and try to force it into a mass-market reality. But “good enough” doesn’t trigger dopamine. If your product has even one “killer issue”—a clunky interface, an off-putting scent, or a confusing price point—you are mainlining pain into your customer’s brain.
The Keurig Kold Lesson
I’ve lived this… During the development of the Keurig Kold, we were trying to reinvent the way people drink cold soda. It was a bold Business Art project. But we scaled before the thermodynamics were truly “smokingly cool.” We ignored the biological friction of a machine that was too loud and a price point that triggered the amygdala’s fear response. We scaled the beta, and the market responded with a hard “no.”
The Cortisol Cascade
When you launch prematurely, you aren’t just losing money. You are creating a negative spiral. The customer’s brain registers your brand as a source of frustration, triggering a cascade of cortisol. Once that association is made, your brand becomes a “threat” to avoid, making Version 2.0 an even harder sell.
The Neurochemistry of Rejection
Humans are hardwired to move toward pleasure and away from pain. This 200,000-year-old secret is the centerpiece of all value creation. If your product launch isn’t architected to trigger a specific chemical response, you are just throwing money at the wall.
Logic is the Booby Prize
Board Chairs often get trapped in “logic.” They think features and benefits win. They don’t. Decisions are made in the primitive brain—the reward center—long before the conscious mind can rationalize them. If your launch doesn’t create an immediate, visceral “I want that” feeling, no amount of marketing logic will save you.
Aesthetics as a Vaccine
A “galleriable” product design isn’t just about vanity. It acts as a vaccine against commoditization. When something is beautiful and intuitive, it triggers endorphins and dopamine. This “Business Art” makes the customer more forgiving of minor flaws and more likely to advocate for your brand.
The Remedy: The Last Experiment First
If you want to ensure your launch is an investable proposition, you must run the Last Experiment First. Most companies save the hardest questions for the end of the development cycle. They spend millions on “safe” steps, only to find out at the very end that the customer doesn’t actually prefer the product.
Flip the Script
Identify the one thing that must be true for the customer to fall in love with your product. Is it the taste? The speed? The “totally smokingly cool” design?
Test that high-fidelity “dream version” first. Use your capital to prove the Rx of Preference before you build the factory. If you can’t get a high purchase intent score on a prototype that delivers a total pleasure-chemical takeover, you shouldn’t be launching at all.
